Product Usage
This product is intended for research purposes only. All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Dual Regulator DIA-39-C20
PURITY ≥99%/LOT LL-0824/HPLC VERIFIED
Select Your Dosage
Dual Regulator DIA-39-C20 — GLP-1/GIP Dual Receptor Agonist.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
03 / Research Context
Research context
DIA-39-C20 is a dual incretin receptor agonist targeting GLP-1 and GIP receptors. It modulates glucose homeostasis and insulin secretion with synergistic efficacy in metabolic and cellular assays.
Key research areas
- Dual GLP-1/GIP receptor agonism
- Superior to single-receptor agonists in studies
- Enhanced weight reduction and glycemic control
- Synergistic insulin secretion modulation
- Cardiovascular risk marker improvement
- Broadest dosage range available (5-120mg)
Handling & reconstitution
Supplied as a lyophilized powder. Bacteriostatic water is the recommended solvent for reconstitution in research applications. Store unreconstituted product at -20°C; reconstituted solutions should be stored at 2-8°C and used within 14–30 days.
Research use only. Not for human consumption.
Product specifications
| Type | GLP-1/GIP Dual Receptor Agonist |
| Purity | 99%+ |
| Appearance | Lyophilized Powder |
| Storage | 2-8°C |
